Calprotectin Is a Useful Tool in Distinguishing Coexisting Irritable Bowel-Like Symptoms from That of Occult Inflammation among Inflammatory Bowel Disease Patients in Remission

Table 1

Sociodemographic and clinical data among IBD patients with or without IBS.

		UC			CD
	IBS negative	IBS positive	𝑃 value	IBS negative	IBS positive	𝑃 value
	𝑛=46	𝑛=15		𝑛=22	𝑛=6
Age—mean (SD)	50.2 (15.6)	38.7 (10.7)	0.01	38.9 (16.3)	30.5 (8.6)	Ns
Gender:
% female	43	33	Ns	73	100	Ns
Disease duration—mean (SD)	9.3 (10.7)	6.8 (4.9)	Ns	6.2 (5.8)	8.8 (8.6)	Ns
Calprotectin	189.3 (348.7)	347.7 (443.9)	Ns	156.6 (193.3)	439.0 (508.7)	0.04
Smoking:
% yes	26	27	Ns	32	17	Ns
Employment:
% yes	61	73	Ns	68	83	Ns

IBD: inflammatory bowel disease, IBS: irritable bowel syndrome, UC: ulcerative colitis, CD: Crohn’s disease, SD: standard deviation, and Ns: no significance.